Navigation Links
Genome of bacteria responsible for tuberculosis of olive tree sequenced
Date:6/1/2010

Researchers at the Public University of Navarra, the Polytechnic University of Madrid (CBGP), the University of Malaga, the University of Wisconsin and the Valencian Institute of Agricultural Research have managed to sequence the genome of the bacteria responsible for tuberculosis in the olive tree. The study, included in the June issue of Environmental Microbiology, represents the first sequencing of the genome of a pathogenic bacteria undertaken in Spain, being the first genome known worldwide of a pathogenic Pseudomonas in woody plants.

The sequencing of the genome of this pathogen opens the doors to the identification of the genes responsible for the virulence of this bacteria and its survival on the philosphere (leaf surface), thus facilitating the design of specific strategies in the fight against the disease and enabling drawing up programmes for the genetic improvement of olive groves.

Pseudomonas savastanoi is the agent that gives rise to tuberculosis in the olive tree, a disease that causes important losses in the olive crops in Spain. Trees affected present tumours (known as verrucas) that can grow to several centimetres diameter in trunks, branches, stalks and buds. Diseased trees are less robust and have less growth, to the point of being non-productive if the attack is very intense. To date, due to the absence of effective methods of control, preventive strategies have been carried out, reducing populations of bacteria with phytosanitary treatment.

New strategies

Plant diseases produced by pathogenic microorganisms not only reduce production but can also alter the quality of the food and drastically diminish the commercial value of the crops. The new strategies for disease control today involve the analysis of information contained in the genome of pathogenic organisms. Similar to what has happened with the human genome, this technology is generating a great amount of valuable information for the development of innovative technologies, that will enable identifying and controlling the pathogen as well as obtaining new varieties of the host plant that have greater resistance to the disease.


'/>"/>

Contact: Oihane Lakar
o.lakar@elhuyar.com
0034-943-363-040
Elhuyar Fundazioa
Source:Eurekalert  

Related biology news :

1. Powerful genome barcoding system reveals large-scale variation in human DNA
2. Genome comparison tools found to be susceptible to slip-ups
3. DOE JGI produces new QC tool for microbial genomes
4. Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning
5. Neandertal genome sequence published in Science
6. CSHL team helps Neandertal Genome Project compare differences between Neandertals and modern humans
7. Complete Neanderthal genome sequenced
8. Neanderthal genome yields insights into human evolution and evidence of interbreeding
9. Sequencing of first frog genome sheds light on treating disease
10. New Stanford tool enables wider analyses of genome deep sequencing
11. Scientists report first genome sequence of frog
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genome of bacteria responsible for tuberculosis of olive tree sequenced
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology: